MedTrace Logo

The Jordan Atrial Fibrillation Study: Baseline Risk Scores and One Year Outcome

NCT03917992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2020

Last updated 2023-05-25

No results posted yet for this study

Summary

The Jordanian AF study, the first of its kind in Jordan, will evaluate patients with AF in an in-patient and out-patient settings. The morbidity and mortality associated with AF has not been studied in this region especially with the relation to the HAD BLED and CHADS VAC score.

Conditions

Sponsors & Collaborators

  • Ayman J Hammoudeh, MD, FACC

    lead OTHER

Principal Investigators

  • Ayman Hammoudeh, MD, FACC · Cardiology Dept, Istishari Hospital, Amman, Jordan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-25
Primary Completion
2021-11-25
Completion
2021-11-25

Countries

  • Jordan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03917992 on ClinicalTrials.gov